513 related articles for article (PubMed ID: 28968188)
1. The Opioid Epidemic: Crisis and Solutions.
Skolnick P
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():143-159. PubMed ID: 28968188
[TBL] [Abstract][Full Text] [Related]
2. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
[TBL] [Abstract][Full Text] [Related]
3. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
4. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
5. Opioids with abuse-deterrent properties: A regulatory and technological overview.
Haddox JD
J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids.
Roxburgh A; Hall WD; Gisev N; Degenhardt L
Drug Alcohol Depend; 2019 Dec; 205():107533. PubMed ID: 31704378
[TBL] [Abstract][Full Text] [Related]
7. The nexus of opioids, pain, and addiction: Challenges and solutions.
Henningfield JE; Ashworth JB; Gerlach KK; Simone B; Schnoll SH
Prev Med; 2019 Nov; 128():105852. PubMed ID: 31634511
[TBL] [Abstract][Full Text] [Related]
8. Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis.
Yarborough BJ; Stumbo SP; Janoff SL; Yarborough MT; McCarty D; Chilcoat HD; Coplan PM; Green CA
Drug Alcohol Depend; 2016 Oct; 167():49-56. PubMed ID: 27520885
[TBL] [Abstract][Full Text] [Related]
9. Use of risk mitigation practices by family nurse practitioners prescribing opioids for the management of chronic nonmalignant pain.
Chaudhary S; Compton P
Subst Abus; 2017; 38(1):95-104. PubMed ID: 27897471
[TBL] [Abstract][Full Text] [Related]
10. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
[TBL] [Abstract][Full Text] [Related]
11. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review.
Stoicea N; Costa A; Periel L; Uribe A; Weaver T; Bergese SD
Medicine (Baltimore); 2019 May; 98(20):e15425. PubMed ID: 31096439
[TBL] [Abstract][Full Text] [Related]
13. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.
Dowell D; Haegerich TM; Chou R
JAMA; 2016 Apr; 315(15):1624-45. PubMed ID: 26977696
[TBL] [Abstract][Full Text] [Related]
14. Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016-June 2017.
Mattson CL; O'Donnell J; Kariisa M; Seth P; Scholl L; Gladden RM
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(34):945-951. PubMed ID: 30161105
[TBL] [Abstract][Full Text] [Related]
15. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
Cheatle MD
Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
[TBL] [Abstract][Full Text] [Related]
16. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
17. CE: Appropriate Use of Opioids in Managing Chronic Pain.
Denenberg R; Curtiss CP
Am J Nurs; 2016 Jul; 116(7):26-38. PubMed ID: 27294667
[TBL] [Abstract][Full Text] [Related]
18. A crisis of opioids and the limits of prescription control: United States.
Kertesz SG; Gordon AJ
Addiction; 2019 Jan; 114(1):169-180. PubMed ID: 30039595
[TBL] [Abstract][Full Text] [Related]
19. Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model.
Kumar VM; Agboola F; Synnott PG; Segel C; Webb M; Ollendorf DA; Banken R; Chapman RH
Value Health; 2019 Apr; 22(4):416-422. PubMed ID: 30975392
[TBL] [Abstract][Full Text] [Related]
20. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
